Optic neuritis occurring with anti-tumour necrosis factor α therapy

Annals of the Rheumatic Diseases

Volumn 66, Issue 9, 2007, Pages 1255-1258

  Simsek, Ismail ^a   Erdem, Hakan ^a   Pay, Salih ^a   Sobaci, Gungor ^a   Dinc, Ayhan ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; ISONIAZID; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; INJECTION SITE REACTION; JUVENILE RHEUMATOID ARTHRITIS; MALE; OPTIC NEURITIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME; VISUAL DISORDER;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; OPTIC NEURITIS; PREDNISOLONE; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548149410     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.066787     Document Type: Article

References (15)

1. Khanna D, McMahon M, Furst DE. Safety of tumour necrosis factor-alpha antagonists. Drug Saf 2004;27:307-24.
2. Mohan N, Edwards ET, Cupps TR, Oliverio PJ, Sandberg G, Crayton H, et al. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 2001;44:2862-9.
3. Thomas CW Jr, Weinshenker BG, Sandborn WJ. Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn's disease. Inflamm Bowel Dis 2004;10:28-31.
4. Shin IS, Baer AN, Kwon HJ, Papadopoulos EJ, Siegel JN. Guillain-Barre and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy. Arthritis Rheum 2006;54:1429-34.
5. Bhatti MT, Schmitt NJ, Beatty RL. Acute inflammatory demyelinating optic neuritis: current concepts in diagnosis and management. Optometry 2005;76:526-35.
6. Noguera-Pons R, Borras-Blasco J, Romero-Crespo I, Anton-Torres R, Navarro-Ruiz A, Gonzalez-Ferrandez JA. Optic neuritis with concurrent etanercept and isoniazid therapy. Ann Pharmacother 2005;39:2131-5.
7. Strong BY, Erny BC, Herzenberg H, Razzeca KJ. Retrobulbar optic neuritis associated with infliximab in a patient with Crohn disease. Ann Intern Med 2004;140:W34.
8. Foroozan R, Buono LM, Sergott RC, Savino PJ. Retrobulbar optic neuritis associated with infliximab. Arch Ophthalmol 2002;120:985- 7.
9. ten Tusscher MP, Jacobs PJ, Busch MJ, de Graaf L, Diemont WL. Bilateral anterior toxic optic neuropathy and the use of infliximab. BMJ 2003;326:579.
10. Mejico LJ. Infliximab-associated retrobulbar optic neuritis. Arch Ophthalmol 2004;122:793-4.
11. Tran TH, Milea D, Cassoux N, Bodaghi B, Bourgeois P, LeHoang P. [Optic neuritis associated with infliximab]. J Fr Ophtalmol 2005;28:201-4.
12. Tauber T, Turetz J, Barash J, Avni I, Morad Y. Optic neuritis associated with etanercept therapy for juvenile arthritis. J AAPOS 2006;10:26-9.
13. Chung JH, Van Stavern GP, Frohman LP, Turbin RE. Adalimumab-associated optic neuritis. J Neurol Sci 2006;244:133-6.
14. Robinson WH, Genovese MC, Moreland LW. Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 2001;44:1977-83.
15. Goldman AL, Braman SS. Isoniazid: a review with emphasis on adverse effects Chest 1972;62:71-77.